By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Voyager Therapeutics 

75 Sidney Street

Cambridge  Massachusetts  02139  U.S.A.
Phone: 910-509-3977 Fax: n/a



Company News
Voyager Therapeutics (VYGR) To Host Fourth Quarter And Full Year 2016 Financial Results Conference Call 3/8/2017 8:21:04 AM
Voyager Therapeutics (VYGR) Appoints Jane Pritchett Henderson As Chief Financial Officer 1/3/2017 8:53:19 AM
MRI Interventions (MRIC)’ Clearpoint Neuro Navigation System Utilized In Voyager Therapeutics (VYGR)’ VY-AADC01 Phase Ib Trial; Positive Interim Results Reported 12/8/2016 7:18:28 AM
Voyager Therapeutics (VYGR) Soars as Parkinson’s Drug Shines in Early-Stage Trial 12/8/2016 5:48:18 AM
DNA Brain Injection Could Help Control Parkinson's Symptoms, Voyager Therapeutics (VYGR) Reveals 8/23/2016 6:26:43 AM
MRI' Clearpoint Neuro Navigation Technology Highlighted In Voyager Therapeutics (VYGR) Interim Parkinson’s Disease Gene Therapy Study Results 6/24/2016 8:11:58 AM
Voyager Therapeutics (VYGR) Announces Interim Phase 1b Surgical Results For VY-AADC01 In Advanced Parkinson’s Disease 6/22/2016 9:25:16 AM
Voyager Therapeutics (VYGR) Provides First Quarter 2016 Investor Update 5/12/2016 10:14:56 AM
Voyager Therapeutics (VYGR) Promotes Jeff Goater To Chief Financial Officer 2/3/2016 9:07:14 AM
Voyager Therapeutics (VYGR) Announces Closing Of Initial Public Offering, Including Full Exercise Of Option To Purchase Additional Shares 11/17/2015 7:25:58 AM